BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
33465778
Number of visits today
1806
Number of downloads
16647294
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: El-Haggar SM, Hegazy SK, M Abd-Elsalam S, Bahaa MM. Open-label pilot study of ethosuximide as adjunctive therapy for relieving abdominal pain related to Irritable Bowel Syndrome. J Clin Pharm Ther 2021. [PMID: 34726293 DOI: 10.1111/jcpt.13556] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Nabizadeh H, Mohammadi A, Dolatabadi R, Nojavan S, Vahabizad F. Sensitive determination of ethosuximide in human fluids by electromembrane extraction coupled with high performance liquid chromatography ultraviolet spectroscopy. J Chinese Chemical Soc 2022. [DOI: 10.1002/jccs.202200423] [Reference Citation Analysis]
2 El-haggar SM, Hegazy SK, Abd-elsalam SM, Elkaeed EB, Al-karmalawy AA, Bahaa MM. A Potential Role of Ethosuximide and Pentoxifylline in Relieving Abdominal Pain in Irritable Bowel Syndrome Patients Treated with Mebeverine: A Randomized, Double-Blind, Placebo-Controlled Trial. JIR 2022;Volume 15:1159-72. [DOI: 10.2147/jir.s346608] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Hoppanova L, Lacinova L. Voltage-dependent CaV3.2 and CaV2.2 channels in nociceptive pathways. Pflugers Arch 2022. [PMID: 35043234 DOI: 10.1007/s00424-022-02666-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345